Oral Oncology

Article	Citations
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma	308
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma	95
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study	64
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model	56
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis	55
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review	47
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?	45
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma	45
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2	43
P-167 Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Elective Neck Dissection	42
Editorial Board/Aims & Scope	39
P28 Head and neck cancer cells differentiate resembling their tissue of origin	37
P-86 Tumor Recurrence on Pectoralis Major Myocutaneous Flap	35
Salvage Treatment in Isolated Regional Recurrent Head and Neck Squamous Cell Carcinoma	33
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders	33
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]	32
P-140 Clinical outcomes following pharyngolaryngectomy reconstruction: a 20-year single centre study	32
P-22 Artifact reduction in head and neck CT images using polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyphenylsulfone (PPSU) and polyether (PE) polymer implants in mandible reconstruct	31
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies	31
P-72 Hypofractionated, Dose redistributed RAdiotherapy for head and neck squamous cell carcinoma (HYDRA)	31
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study	30
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”	30
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)	29
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment	29
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection	28

The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis	28
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection	28
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study	28
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients	27
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study	26
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes	26
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database	26
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]	26
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study	26
Radiation-induced sarcomas of the craniofacial region: A systematic review	26
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions	26
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	25
Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma	25
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer	25
Objective evaluation of orbito-zygomatic reconstruction with scapular tip free flaps to restore facial projection and orbital volume	25
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies	25
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients	24
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review	24
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis	24
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma	24
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer	24
Overestimated risk of transformation in oral lichen planus	23
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”	23
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge	23
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”	23
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker	22
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis	21
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study	21
Required time for pre-oncological dental management – A rapid review of the literature	21
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–2021	21
Palliative care utilization among head and neck cancer patients: A population-based analysis	20
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma	20
Artificial intelligence for oral cancer diagnosis: What are the possibilities?	20
Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma	20
Elective neck dissection: Are we bound to outdated concepts?	19
Primary intraosseous malignant peripheral nerve sheath tumor of the mandible: An unusual presentation mimicking a benign lesion	19
Prediction of risk factors for pharyngo-cutaneous fistula after total laryngectomy using artificial intelligence	19
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma	19
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?	19
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma	19
Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones	18
Innovative applications of hybrid operating room in otolaryngology: A pilot study	18
O1.3 Awareness of HPV-associated oropharyngeal cancer among the general population and general practitioners in the Netherlands: Cross-sectional study	18
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients	18
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers	18
Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions	18
Selective autophagy as a potential therapeutic target for oral cancer	18
Osteoblastoma of the maxilla: A case report and review of the literature	18
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials	18
Comment on “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”	18

P-194 Risk factors for central lymph node metastases in patients with cN0 papillary microcarcinoma: An analysis of 306 patients at a single institution	17
Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus related squamous cell cancer	17
Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer	17
Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis:	17
P-185 Safety and effectiveness in daily clinical practice of the Cetuximab-Docetaxel-Cisplatin protocol in recurrent head and neck cancer and/or first-line in metastatic disease	17
Do head and neck cancer patients in randomized trials represent the population in daily practice?	17
ChatGPT: Empowering dentistry with future possibilities	17
P-209 Social and Sexual Health of Thyroid Cancer Survivors Two and Five Years After Diagnosis: The VICAN Survey	17
P-162 Time dependency of adjuvant therapy in advanced head-and-neck-squamous-cell-carcinoma of unknown primary (CUP)-patients	17
P-19 The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients	17
Editorial Board	17
P35 Spatial proteomics and metabolomics investigations in head & neck cancers	16
Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]	16
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?	16
P-28 The potential of MET immunoreactivity for prediction of lymph node metastasis in early tongue squamous cell carcinoma	16
P-175 TORS in Athens, Greece. Initial experience	16
FLASH radiotherapy in head and neck cancer: Myth or reality?	16
Completion thyroidectomy for intermediate risk factors after thyroid lobectomy	16
P-168 Pain and analgesic requirements in transoral robotic surgery according to surgical subsite and location	16
“In response to “Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia”	16
P25 The role of ultrasound elastography for clinical neck staging in HPV-related oropharyngeal cancer	16
P-248 Clinical factors associated with the risk of malignancy in indeterminate pulmonary nodules in patients with head and neck cancer	16
P-103 Adult lymphangioma of the deep lobe of the parotid gland: an original surgical management	15
Association between E-cigarette use and oral HPV-16 infection	15
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity	15
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma	15
Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions	15
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis	15
Editorial Board/Aims & Scope	15
P29 Comparison of selected clinical factors and treatment results according to HPV status in patients with oropharyngeal cancer treated with radiotherapy alone or combined with chemotherapy	15
Impact of HPV status on immune responses in head and neck squamous cell carcinoma	15
“Time is not to be wasted”	14
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review	14
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors	14
Pain management with popliteal block for fibular graft harvesting in head and neck reconstruction; a randomised double-blind placebo-controlled study	14
Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal c	14
Invasive oral squamous cell carcinoma induced by concurrent smokeless tobacco and creamy snuff use: A case report	14
Positive margins matter regardless of subsequent resection findings	14
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy	14
Necrotizing sialometaplasia: A diagnostic challenge	14
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial	14
Response to the comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”	14
Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology	14
Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI	14
Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma	13
The case against lingual mucosectomy	13
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma	13
Unfamiliar case of metastatic myxoid leiomyosarcoma of mandible	13
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma – “Need for incorporation of sub classification of pT4b lesions”	13
O3.3 Proximity ligation-based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas	13
Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer	13
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma	13
Comment on, “Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes”	13
The importance of early treatment of oral squamous cell carcinoma: Case report	13
Covid-19 pandemic and head and neck cancers, what should we expect?	13
Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue	13
Correspondence on “Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040”	13
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma	13
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unre	13
Ferroptosis: An emerging therapeutic target for oral cancer	13
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas	13
Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!	13
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer	13
P-222 How behavioural challenges effect surgical management	13
Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case	13
Two-stage surgery for the treatment of nonmelanoma skin cancer of the face: Change of surgical strategy during COVID-19 pandemic	13
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy	13
Lymph node yield and ratio in the central compartment	12
Can imaging alone replace panendscopy as a 'gold standard’ investigation for patients with low risk features for oropharyngeal cancer?	12
P-26 Factors associated with 18-month mortality in patients with oral squamous cell carcinoma: a population-based study	12
Evaluation of pembrolizumab monotherapy in patients with salivary gland carcinoma in the phase 2 KEYNOTE-158 study	12
Comment on “Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review”	12
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study	12
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma	12
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor	12
P-73 Multidisciplinary management of recurrent nasopharyngeal carcinoma after chemo-radiotherapy protocol	12
Editorial Board	12
CD271high cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma	12
Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma	12
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy	12

P-12 Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)	12
The submandibular gland in neck dissection: A necessary casualty or a hapless victim?	12
A rare case of extranodal Rosai Dorfman disease of zygoma	12
P-23 The utility of the MOSAIQ oncology information system in head and neck cancer research	12
P-62 Helical Intensity Modulated Radiotherapy 18 FDG PET guided in locally advanced oropharyngeal cancer: a mono-institutional experience	12
Metformin and oral cancer	12
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma	12
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?	12
Perioral reconstruction by submental flap	11
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening	11
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy	11
Telescreening as an alternate modality for early detection of oral cancer	11
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma	11
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?	11
Endoscopic-assisted multi-portal compartmental resection of the masticatory space in oral cancer: Anatomical study and preliminary clinical experience	11
Commentary on “Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients”	11
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma	11
O1.2 Single cell RNA sequencing allows mapping of HPV transcripts in head and neck cancer epithelial cells	11
Hemangiomatous adenomatoid odontogenic tumor of maxilla: A new variant?	11
Editorial Board/Aims & Scope	11
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery	11
Pain management following transoral robotic surgery for oropharyngeal squamous cell Carcinoma: A systematic review	11
Comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”	11
Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis	11
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery	11
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)	11
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells – Multifunctional therapeutic approach against oral cancer	11
Single-cell profiling of tumor-infiltrating TCF1/TCF7+ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer	11
Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy	11
Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies	11
Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?	11
Mammary analogue secretory carcinoma presenting as localized hematoma of the palate	11
Editorial Board	11
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck	11
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial	11
Letter to the editor, “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer”	11
Confusion prevails in severe oral epithelial dysplasia with microinvasion versus microinvasive carcinoma	11
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area	11
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma	10
P-36 Structural monitoring patient reported outcome in palliative head and neck cancer care, what can we learn to improve patient centered care?	10
P-75 Reirradiation in head and neck recurrent cancer or second primary. Our experience	10
P-215 The role of prehabilitation in frail patient with a head and neck cancer	10
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 s	10
Tongue cancer in non-smoking and non-alcoholic mother and daughter	10
P-199 Tackling Monster thyroids: Our Experience at a Tertiary Care Centre	10
O3.2 Loss of LRP1B expression drives chemo and radiation resistance in HPV-positive head and neck cancer	10
P-61 Comparison of Concurrent Chemoradiotherapy or Radiotherapy alone after Induction Chemotherapy for Hypopharyngeal Cancer	10
P-7 Surgical versus Organ preservation protocol for stage T3/T4 laryngeal and hypopharyngeal cancer	10
Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequentia	10
The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations	10
Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation	10
P-177 FDG-PET/CT-based prognostic survival model after surgery for head and neck cancer	10
P-259 Immunodeficiency and Oral Squamous Cell Carcinoma: Our Experience	10
Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies	10
P-151 Thesis: Quality of Life and functional outcomes after treatment for oropharyngeal squamous cell carcinoma (OPSCC)	10
Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131]	10
P-243 HPV-associated oropharyngeal neuroendocrine carcinoma: case report of a rare aggressive new entity and review of the literature	10
Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: An immunohistochemical study	10
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study	9
Corrigendum to “Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer” [Oral Oncol. 51 (2015) 565–569]	9
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-	9
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma	9
Analysis of the effects of mandibular reconstruction based on microvascular free flaps after oncological resections in 21 patients, using 3D planning, surgical templates and individual implants	9
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice	9
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer	9
Letter to the Editor: “Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma”	9
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer	9
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: RestorabiteTM	9
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments	9
Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck	9
Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer	9
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study	9
Anti-epidermal growth factor receptor targeted therapy-associated ulcerations	9
Corrigendum to “Flash radiotherapy-gateway to promised land or another mirage” [Oral Oncol. 139 (2023) 106342]	9
Thyroid volumes after intensity‐modulated radiotherapy as predictors of radiation‐induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study	9
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation	9
The impact of physician’s characteristics on decision-making in head and neck oncology: Results of a national survey	9
Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity	9
Correlation between radiological, macroscopic and microscopic depth of invasion in oral squamous cell carcinoma: A prospective study using contrast-enhanced computed tomography	9
Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis	9
P-205 In vivo multispectral optoacoustic tomography of thyroid nodules	8
P-116 Superficial HDR brachytherapy with custom 3D molds	8
P-233 An Atypical Head and Neck On-Call Week During the COVID-19 Pandemic: The Shape of Things to Come?	8
Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer	8
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens	8
P-189 Report of sequential interventions at a tertiary cancer centre to reduce acute kidney injury rates following concurrent cisplatin with radiotherapy for head and neck cancer	8
P-201 Management Dilemmas in an Extensive Thyroid Malignancy Case	8
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores	8
Personalized intraoral devices in the era of high-technology head and neck radiotherapy: A resource to be explored	8
Corrigendum to “Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer” [Oral On	8
The association of frailty with morbidity and mortality following major mucosal head and neck surgery	8
P-207 Recurrent Laryngeal Nerve Invasion as an Independent Determinant of Complications and Outcome in Papillary Thyroid Cancer	8
P-258 Oral leukoplakia: risk factors associated with malignancy	8
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months	8
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer pat	8